Literature DB >> 23064049

DNA methyltransferase 1 is essential for initiation of the colon cancers.

Rena Morita1, Yoshihiko Hirohashi, Hiromu Suzuki, Akari Takahashi, Yasuaki Tamura, Takayuki Kanaseki, Hiroko Asanuma, Satoko Inoda, Toru Kondo, Satoshi Hashino, Tadashi Hasegawa, Takashi Tokino, Minoru Toyota, Masahiro Asaka, Toshihiko Torigoe, Noriyuki Sato.   

Abstract

DNA methyltransferase 1 (Dnmt1) is essential for the maintenance of hematopoietic and somatic stem cells in mice; however, its roles in human cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are still elusive. In the present study, we investigated DNMT1 functions in the maintenance of human colon CSCs/CICs using the human colon cancer cell line HCT116 (HCT116 w/t) and its DNMT1 knockout cell line (DNMT1(-/-)). The rates of CSCs/CICs were evaluated by side population (SP) analysis, ALDEFLUOR assay and expression of CD44 and CD24. SP, ALDEFLUOR-positive (ALDEFLUOR(+)) and CD44-positive and CD24-positive (CD44(+)CD24(+)) cell rates were lower in DNMT1(-/-) cells than in HCT116 w/t cells. Since CSCs/CICs have higher tumor-initiating ability than that of non-CSCs/CICs, the tumor-initiating abilities were addressed by injecting immune deficient (NOD/SCID) mice. DNMT1(-/-) cells showed less tumor-initiating ability than did HCT116 w/t cells, whereas the growing rate of DNMT1(-/-) cells showed no significant difference from that of HCT116 cells both in vitro and in vivo. Similar results were obtained for cells in which DNMT1 had been transiently knocked-down using gene-specific siRNAs. Taken together, these results indicate that DNMT1 is essential for maintenance of colon CSCs/CICs and that short-term suppression of DNMT1 might be sufficient to disrupt CSCs/CICs.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23064049     DOI: 10.1016/j.yexmp.2012.10.004

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  22 in total

Review 1.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

Review 2.  Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries.

Authors:  Patompon Wongtrakoongate
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

3.  DNA methylation reprogramming of human cancer cells by expression of a plant 5-methylcytosine DNA glycosylase.

Authors:  Teresa Morales-Ruiz; María Victoria García-Ortiz; Iván Devesa-Guerra; Laura Raya-Ruiz; Juan R Tejedor; Gustavo F Bayón; Marta I Sierra; Mario F Fraga; Rafael R Ariza; Teresa Roldán-Arjona
Journal:  Epigenetics       Date:  2018-02-07       Impact factor: 4.528

Review 4.  Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior.

Authors:  Vigneshwari Easwar Kumar; Roshni Nambiar; Cristabelle De Souza; Audrey Nguyen; Jeremy Chien; Kit S Lam
Journal:  Cells       Date:  2022-04-21       Impact factor: 7.666

5.  Comprehensive Analysis of VCAN Expression Profiles and Prognostic Values in HCC.

Authors:  Guangshun Sun; Wubin Zheng; Pengyu Tan; Jin Zhou; Weiwei Tang; Hongyong Cao; Li Liu; Xuesong Shi; Zhouxiao Li; Wenling Zhang
Journal:  Front Genet       Date:  2022-06-24       Impact factor: 4.772

Review 6.  Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis.

Authors:  Zhishan Wang; Chengfeng Yang
Journal:  Semin Cancer Biol       Date:  2019-01-11       Impact factor: 15.707

Review 7.  Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.

Authors:  Yadav Sangeeta Muthyalaiah; Bhavana Jonnalagadda; Cordelia Mano John; Sumathy Arockiasamy
Journal:  Glycoconj J       Date:  2022-01-22       Impact factor: 2.916

8.  DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster.

Authors:  Sladjana Zagorac; Sonia Alcala; Gustavo Fernandez Bayon; Tony Bou Kheir; Matthieu Schoenhals; Anna González-Neira; Mario Fernandez Fraga; Alexandra Aicher; Christopher Heeschen; Bruno Sainz
Journal:  Cancer Res       Date:  2016-06-03       Impact factor: 12.701

Review 9.  DNA methyltransferases: a novel target for prevention and therapy.

Authors:  Dharmalingam Subramaniam; Ravi Thombre; Animesh Dhar; Shrikant Anant
Journal:  Front Oncol       Date:  2014-05-01       Impact factor: 6.244

10.  A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype.

Authors:  Ryan W Serra; Minggang Fang; Sung Mi Park; Lloyd Hutchinson; Michael R Green
Journal:  Elife       Date:  2014-03-12       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.